"The Taro transaction closed in late Q1FY25. Currently, the position integration activities are going on and we expect that we will be able to complete the integration work in the near term," said CS Muralidharan, Group CFO of Sun Pharma.
from Video News in CNBCTV18, Video Latest News, Video News https://ift.tt/zL3MIJA
Sun Pharma maintains topline growth guidance for all businesses
सोमवार, अगस्त 05, 2024
0
